Scaffold-mediated lentiviral transduction for functional tissue engineering of cartilage

Proceedings of the National Academy of Sciences of the United States of America

Volumn 111, Issue 9, 2014, Pages

  Brunger, Jonathan M ^a,b   Huynh, Nguyen P T ^a   Guenther, Caitlin M ^a,b   Perez Pinera, Pablo ^b   Moutos, Franklin T ^a   Sanchez Adams, Johannah ^a   Gersbach, Charles A ^a,b   Guilak, Farshid ^a,b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b Duke University   (United States)

Author keywords

Biomaterials; Chondrocyte; Gene therapy; Genetic engineering; Regenerative medicine

Indexed keywords

LENTIVIRUS VECTOR; POLYCAPROLACTONE; POLYLYSINE; TRANSFORMING GROWTH FACTOR BETA3;

ARTICLE; CARTILAGE; CELL DIFFERENTIATION; CHONDROGENESIS; EXTRACELLULAR MATRIX; GENE EXPRESSION; GENE TARGETING; HUMAN; HUMAN CELL; MESENCHYMAL STEM CELL; NONHUMAN; PRIORITY JOURNAL; STEM CELL; TISSUE ENGINEERING; TISSUE REPAIR; VIRAL GENE DELIVERY SYSTEM;

BIOMATERIALS; CHONDROCYTE; GENE THERAPY; GENETIC ENGINEERING; REGENERATIVE MEDICINE;

ANALYSIS OF VARIANCE; BIOMECHANICAL PHENOMENA; CELL DIFFERENTIATION; CHONDROGENESIS; DNA PRIMERS; EXTRACELLULAR MATRIX; FLOW CYTOMETRY; GENE TRANSFER TECHNIQUES; HUMANS; IMMUNOHISTOCHEMISTRY; LENTIVIRUS; MESENCHYMAL STROMAL CELLS; MICROSCOPY, ELECTRON, SCANNING; MICROSCOPY, FLUORESCENCE; POLYESTERS; POLYLYSINE; REGENERATIVE MEDICINE; TISSUE ENGINEERING; TISSUE SCAFFOLDS; TRANSDUCTION, GENETIC; TRANSFORMING GROWTH FACTOR BETA3;

EID: 84895797798     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1321744111     Document Type: Article

References (79)

1. Kock L, van Donkelaar CC, Ito K (2012) Tissue engineering of functional articular cartilage: The current status. Cell Tissue Res 347(3):613-627.
2. Butler DL, Goldstein SA, Guilak F (2000) Functional tissue engineering: The role of biomechanics. J Biomech Eng 122(6):570-575.
3. Gao J, Yao JQ, Caplan AI (2007) Stem cells for tissue engineering of articular cartilage. Proc Inst Mech Eng H 221(5):441-450.
4. Kretlow JD, Klouda L, Mikos AG (2007) Injectable matrices and scaffolds for drug delivery in tissue engineering. Adv Drug Deliv Rev 59(4-5):263-273.
5. LeBaron RG, Athanasiou KA (2000) Ex vivo synthesis of articular cartilage. Biomaterials 21(24):2575-2587.
6. Bian L, Zhai DY, Zhang EC, Mauck RL, Burdick JA (2012) Dynamic compressive loading enhances cartilage matrix synthesis and distribution and suppresses hypertrophy in hMSC-laden hyaluronic acid hydrogels. Tissue Eng Part A 18(7-8):715-724.
7. Moffat KL, et al. (2009) Novel nanofiber-based scaffold for rotator cuff repair and augmentation. Tissue Eng Part A 15(1):115-126.
8. Corsi KA, Schwarz EM, Mooney DJ, Huard J (2007) Regenerative medicine in orthopaedic surgery. J Orthop Res 25(10):1261-1268.
9. Stern-Straeter J, Riedel F, Bran G, Hörmann K, Goessler UR (2007) Advances in skeletal muscle tissue engineering. In Vivo 21(3):435-444.
10. Wu Y, et al. (2010) Electrosprayed core-shell microspheres for protein delivery. Chem Commun 46(26):4743-4745.
11. Lee CH, et al. (2010) Regeneration of the articular surface of the rabbit synovial joint by cell homing: A proof of concept study. Lancet 376(9739):440-448.
12. Reyes CD, Petrie TA, Burns KL, Schwartz Z, García AJ (2007) Biomolecular surface coating to enhance orthopaedic tissue healing and integration. Biomaterials 28(21): 3228-3235.
13. Stahl PJ, Yu SM (2012) Encoding cell-instructive cues to PEG-based hydrogels via triple helical peptide assembly. Soft Matter 8:10409-10418.
14. Hwang NS, Varghese S, Li H, Elisseeff J (2011) Regulation of osteogenic and chondrogenic differentiation of mesenchymal stem cells in PEG-ECM hydrogels. Cell Tissue Res 344(3):499-509.
15. Shea LD, Smiley E, Bonadio J, Mooney DJ (1999) DNA delivery from polymer matrices for tissue engineering. Nat Biotechnol 17(6):551-554.
16. Basile P, et al. (2008) Freeze-dried tendon allografts as tissue-engineering scaffolds for Gdf5 gene delivery. Mol Ther 16(3):466-473.
17. Dang JM, Leong KW (2006) Natural polymers for gene delivery and tissue engineering. Adv Drug Deliv Rev 58(4):487-499.
18. Liao IC, Chen S, Liu JB, Leong KW (2009) Sustained viral gene delivery through coreshell fibers. J Control Release 139(1):48-55.
19. Fishbein I, et al. (2013) Adenoviral vector tethering to metal surfaces via hydrolyzable cross-linkers for the modulation of vector release and transduction. Biomaterials 34 (28):6938-6948.
20. Gersbach CA, Coyer SR, Le Doux JM, García AJ (2007) Biomaterial-mediated retroviral gene transfer using self-assembled monolayers. Biomaterials 28(34):5121-5127.
21. Cucchiarini M, Orth P, Madry H (2013) Direct rAAV SOX9 administration for durable articular cartilage repair with delayed terminal differentiation and hypertrophy in vivo. J Mol Med 91(5):625-636.
22. Mueller MB, Tuan RS (2008) Functional characterization of hypertrophy in chondrogenesis of human mesenchymal stem cells. Arthritis Rheum 58(5):1377-1388.
23. Mow VC, Kuei SC, Lai WM, Armstrong CG (1980) Biphasic creep and stress relaxation of articular cartilage in compression? Theory and experiments. J Biomech Eng 102(1): 73-84.
24. Ousema PH, et al. (2012) The inhibition by interleukin 1 of MSC chondrogenesis and the development of biomechanical properties in biomimetic 3D woven PCL scaffolds. Biomaterials 33(35):8967-8974.
25. Valonen PK, et al. (2010) In vitro generation of mechanically functional cartilage grafts based on adult human stem cells and 3D-woven poly(epsilon-caprolactone) scaffolds. Biomaterials 31(8):2193-2200.
26. Kim M, Erickson IE, Choudhury M, Pleshko N, Mauck RL (2012) Transient exposure to TGF-β3 improves the functional chondrogenesis of MSC-laden hyaluronic acid hydrogels. J Mech Behav Biomed Mater 11:92-101.
27. Ballock RT, Heydemann A, Izumi T, Reddi AH (1997) Regulation of the expression of the type-II collagen gene in periosteum-derived cells by three members of the transforming growth factor-beta superfamily. J Orthop Res 15(3):463-467.
28. Mackay AM, et al. (1998) Chondrogenic differentiation of cultured human mesenchymal stem cells from marrow. Tissue Eng 4(4):415-428.
29. Serra R, et al. (1997) Expression of a truncated, kinase-defective TGF-beta type II receptor in mouse skeletal tissue promotes terminal chondrocyte differentiation and osteoarthritis. J Cell Biol 139(2):541-552.
30. Seyedin SM, et al. (1986) Cartilage-inducing factor-A. Apparent identity to transforming growth factor-beta. J Biol Chem 261(13):5693-5695.
31. Leonard CM, et al. (1991) Role of transforming growth factor-beta in chondrogenic pattern formation in the embryonic limb: Stimulation of mesenchymal condensation and fibronectin gene expression by exogenenous TGF-beta and evidence for endogenous TGF-beta-like activity. Dev Biol 145(1):99-109.
32. Madry H, Rey Rico A, Venkatesan JK, Johnstone B, Cucchiarini M (2013) TGF-betareleasing scaffolds for cartilage tissue engineering. Tissue Eng Part B Rev, 10.1089/ten. teb.2013.0271.
33. Neumann AJ, Alini M, Archer CW, StoddartMJ (2013) Chondrogenesis of human bone marrow-derived mesenchymal stem cells is modulated by complex mechanical stimulation and adenoviral-mediated overexpression of bone morphogenetic protein 2. Tissue Eng Part A 19(11-12):1285-1294.
34. Palmer GD, et al. (2005) Gene-induced chondrogenesis of primary mesenchymal stem cells in vitro. Mol Ther 12(2):219-228.
35. Steinert AF, et al. (2009) Enhanced in vitro chondrogenesis of primary mesenchymal stem cells by combined gene transfer. Tissue Eng Part A 15(5):1127-1139.
36. Kramer J, et al. (2000) Embryonic stem cell-derived chondrogenic differentiation in vitro: Activation by BMP-2 and BMP-4. Mech Dev 92(2):193-205.
37. Madry H, Kaul G, Zurakowski D, Vunjak-Novakovic G, Cucchiarini M (2013) Cartilage constructs engineered from chondrocytes overexpressing IGF-I improve the repair of osteochondral defects in a rabbit model. Eur Cell Mater 25:229-247.
38. Weimer A, et al. (2012) Benefits of recombinant adeno-associated virus (rAAV)-mediated insulinlike growth factor I (IGF-I) overexpression for the long-term reconstruction of human osteoarthritic cartilage by modulation of the IGF-I axis. Mol Med 18:346-358.
39. Evans CH, Ghivizzani SC, Robbins PD (2013) Arthritis gene therapy and its tortuous path into the clinic. Transl Res 161(4):205-216.
40. Hu WW, et al. (2009) The use of reactive polymer coatings to facilitate gene delivery from poly (epsilon-caprolactone) scaffolds. Biomaterials 30(29):5785-5792.
41. Hu WW, Lang MW, Krebsbach PH (2008) Development of adenovirus immobilization strategies for in situ gene therapy. J Gene Med 10(10):1102-1112.
42. Hu WW, Wang Z, Hollister SJ, Krebsbach PH (2007) Localized viral vector delivery to enhance in situ regenerative gene therapy. Gene Ther 14(11):891-901.
43. Phillips JE, Burns KL, Le Doux JM, Guldberg RE, García AJ (2008) Engineering graded tissue interfaces. Proc Natl Acad Sci USA 105(34):12170-12175.
44. Shin S, Salvay DM, Shea LD (2010) Lentivirus delivery by adsorption to tissue engineering scaffolds. J Biomed Mater Res A 93(4):1252-1259.
45. Shin S, Shea LD (2010) Lentivirus immobilization to nanoparticles for enhanced and localized delivery from hydrogels. Mol Ther 18(4):700-706.
46. Shin S, Tuinstra HM, Salvay DM, Shea LD (2010) Phosphatidylserine immobilization of lentivirus for localized gene transfer. Biomaterials 31(15):4353-4359.
47. Padmashali RM, Andreadis ST (2011) Engineering fibrinogen-binding VSV-G envelope for spatially-and cell-controlled lentivirus delivery through fibrin hydrogels. Biomaterials 32(12):3330-3339.
48. Lei P, Padmashali RM, Andreadis ST (2009) Cell-controlled and spatially arrayed gene delivery from fibrin hydrogels. Biomaterials 30(22):3790-3799.
49. Jang JH, Schaffer DV, Shea LD (2011) Engineering biomaterial systems to enhance viral vector gene delivery. Mol Ther 19(8):1407-1415.
50. Moutos FT, Freed LE, Guilak F (2007) A biomimetic three-dimensional woven composite scaffold for functional tissue engineering of cartilage. Nat Mater 6(2):162-167.
51. Moutos FT, Guilak F (2010) Functional properties of cell-seeded three-dimensionally woven poly(epsilon-caprolactone) scaffolds for cartilage tissue engineering. Tissue Eng Part A 16(4):1291-1301.
52. LeRoux MA, Guilak F, Setton LA (1999) Compressive and shear properties of alginate gel: Effects of sodium ions and alginate concentration. J Biomed Mater Res 47(1): 46-53.
53. Weisel JW(2004) The mechanical properties of fibrin for basic scientists and clinicians. Biophys Chem 112(2-3):267-276.
54. Spiller KL, Maher SA, Lowman AM (2011) Hydrogels for the repair of articular cartilage defects. Tissue Eng Part B Rev 17(4):281-299.
55. Hu WW, Lang MW, Krebsbach PH (2009) Digoxigenin modification of adenovirus to spatially control gene delivery from chitosan surfaces. J Control Release 135(3):250-258.
56. Wiznerowicz M, Trono D (2005) Harnessing HIV for therapy, basic research and biotechnology. Trends Biotechnol 23(1):42-47.
57. Kumar M, Keller B, Makalou N, Sutton RE (2001) Systematic determination of the packaging limit of lentiviral vectors. Hum Gene Ther 12(15):1893-1905.
58. Zufferey R, et al. (1998) Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery. J Virol 72(12):9873-9880.
59. Dull T, et al. (1998) A third-generation lentivirus vector with a conditional packaging system. J Virol 72(11):8463-8471.
60. Schambach A, Baum C (2008) Clinical application of lentiviral vectors-concepts and practice. Curr Gene Ther 8(6):474-482.
61. Barde I, et al. (2006) Efficient control of gene expression in the hematopoietic system using a single Tet-on inducible lentiviral vector. Mol Ther 13(2):382-390.
62. Atala A, Kasper FK, Mikos AG (2012) Engineering complex tissues. Sci Transl Med 4 (160):160rv112.
63. Reed CR, et al. (2009) Composite tissue engineering on polycaprolactone nanofiber scaffolds. Ann Plast Surg 62(5):505-512.
64. Smith L, Xia Y, Galatz LM, Genin GM, Thomopoulos S (2012) Tissue-engineering strategies for the tendon/ligament-to-bone insertion. Connect Tissue Res 53(2):95-105.
65. Newton CD, Nunamaker DM (1985) Textbook of Small Animal Orthopaedics (Lippincott, Philadelphia).
66. Gouze E, et al. (2007) Transgene persistence and cell turnover in the diarthrodial joint: Implications for gene therapy of chronic joint diseases. Mol Ther 15(6):1114-1120.
67. Gouze E, et al. (2003) Lentiviral-mediated gene delivery to synovium: Potent intraarticular expression with amplification by inflammation. Mol Ther 7(4):460-466.
68. Gouze E, et al. (2002) In vivo gene delivery to synovium by lentiviral vectors. Mol Ther 5(4):397-404.
69. Gersbach CA, Phillips JE, García AJ (2007) Genetic engineering for skeletal regenerative medicine. Annu Rev Biomed Eng 9:87-119.
70. Wiznerowicz M, Trono D (2003) Conditional suppression of cellular genes: Lentivirus vector-mediated drug-inducible RNA interference. J Virol 77(16):8957-8961.
71. Hotta A, et al. (2009) Isolation of human iPS cells using EOS lentiviral vectors to select for pluripotency. Nat Methods 6(5):370-376.
72. Szulc J, Wiznerowicz M, Sauvain MO, Trono D, Aebischer P (2006) A versatile tool for conditional gene expression and knockdown. Nat Methods 3(2):109-116.
73. Salmon P, Trono D (2007) Production and titration of lentiviral vectors. Curr Protoc Hum Genet Chap 12:Unit 12.10.
74. Zhong Q, Inniss D, Kjoller K, Elings VB (1993) Fractured polymer/silica fiber surface studied by tapping mode atomic force microscopy. Surf Sci Lett 290(1-2):L688-L692.
75. Yaszemski MJ (2004) Tissue Engineering and Novel Delivery Systems (Marcel Dekker, New York).
76. Yavari SA, et al. (2013) Fatigue behavior of porous biomaterials manufactured using selective laser melting. Mater Sci Eng C Mater Biol Appl 33(8):4849-4858.
77. Woessner JF, Jr. (1961) The determination of hydroxyproline in tissue and protein samples containing small proportions of this imino acid. Arch Biochem Biophys 93: 440-447.
78. Farndale RW, Buttle DJ, Barrett AJ (1986) Improved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blue. Biochim Biophys Acta 883(2):173-177.
79. Pfaffl MW (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29(9):e45.